Innovations in future directions & emerging therapies in diabetes and endocrinology are revolutionizing the landscape of metabolic disease treatment. Research on pancreatic beta-cell regeneration, stem cell therapy, and gene editing holds potential for long-term diabetes remission. Immunomodulatory approaches aim to halt autoimmune destruction in type 1 diabetes, while artificial intelligence-driven precision medicine is refining treatment plans for type 2 diabetes. Advancements in hormonal therapies, including novel incretin-based drugs and dual-hormone insulin delivery systems, are improving glycemic control. The integration of digital health solutions, closed-loop insulin delivery, and non-invasive glucose monitoring is enhancing patient autonomy. With continuous exploration of new targets, the future of diabetes and endocrinology promises transformative solutions for personalized and preventive care.
Submit your abstract Today
